loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for NCGC00024675-08

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    NCGC00024675-08

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 323Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acasti to Present at the Life Sciences Investor Forum
    Acasti to Present at the Life Sciences Investor Forum

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2945131/0/en/Acasti-to-Present-at-the-Life-Sciences-Investor-Forum.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    Acasti To Participate In H.C. Wainwright Investment Conference
    Acasti To Participate In H.C. Wainwright Investment Conference

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941525/0/en/Acasti-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Annora Pharma's Generic Nimodipine Receives Approvals in US
    Annora Pharma's Generic Nimodipine Receives Approvals in US

    09 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216937

    FDA
    09 Jul 2024
    Share Share
    Amneal Pharms LLC’s Generic Nimodipine Receives Tentative Approval In US
    Amneal Pharms LLC’s Generic Nimodipine Receives Tentative Approval In US

    14 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216256

    FDA
    14 May 2024
    Share Share
    Acasti Pharma Reports Fiscal Year 2023 Operational Results
    Acasti Pharma Reports Fiscal Year 2023 Operational Results

    23 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acasti-pharma-reports-fiscal-year-2023-operational-results-301860778.html

    PR NEWSWIRE
    23 Jun 2023
    Share Share
    Acasti Successfully Submits Pivotal GTX-104 Ph 3 Safety Study Protocol with FDA
    Acasti Successfully Submits Pivotal GTX-104 Ph 3 Safety Study Protocol with FDA

    08 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acasti-successfully-submits-pivotal-gtx-104-phase-3-safety-study-protocol-with-fda-and-implements-strategic-realignment-plan-that-extends-projected-cash-runway-through-calendar-q2-2025-301817840.html

    PR NEWSWIRE
    08 May 2023
    Share Share